Reduced HIV infection and increased survival among HIV-exposed infants using two newly developed point-of-care tests in Papua New Guinea and China.

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

HIV contributes significantly to maternal and infant deaths, largely due to limited access to effective antiretroviral drugs among HIV-infected expectant mothers and their HIV-infected infants. Decisions on what and when to start treatment currently depends on sophisticated laboratory tests, unavailable to many. This research is a world-first intervention study to assess the effectiveness and impact of two newly developed and unique low-cost rapid point-of-care tests.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2017

Funding Scheme: Project Grants

Funding Amount: $952,841.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Family Care

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

CD4 | antiretrovirals | developing countries | diagnostic assay | human immunodeficiency virus (HIV) | infectious diseases | maternal and child health | paediatric | preventive medicine | public health